1.Vitamin D and its effects on cardiovascular diseases: a comprehensive review.
Nonanzit PÉREZ-HERNÁNDEZ ; Gad APTILON-DUQUE ; María Cristina NOSTROZA-HERNÁNDEZ ; Gilberto VARGAS-ALARCÓN ; José Manuel RODRÍGUEZ-PÉREZ ; Ruben BLACHMAN-BRAUN
The Korean Journal of Internal Medicine 2016;31(6):1018-1029
Vitamin D is a molecule that is actively involved in multiple metabolic pathways. It is mostly known for its implications related to calcium metabolism. It has also been determined that it actively participates in the cardiovascular system, influencing blood pressure, coronary artery disease and other vascular diseases, such as heart failure and atrial fibrillation. Furthermore, it has been established that this vitamin is extensively involved in the regulation of both the renin angiotensin aldosterone system and the immune system. In this review, we present the different vitamin D metabolic pathways associated with the cardiovascular pathophysiology, and we include studies in animal and human models, as well as some of the controversies found in the literature. This review also incorporates an overview of the implications in the molecular biology and public health fields.
Animals
;
Atrial Fibrillation
;
Blood Pressure
;
Calcium
;
Cardiovascular Diseases*
;
Cardiovascular System
;
Coronary Artery Disease
;
Heart Failure
;
Humans
;
Immune System
;
Metabolic Networks and Pathways
;
Metabolism
;
Molecular Biology
;
Public Health
;
Renin-Angiotensin System
;
Vascular Diseases
;
Vitamin D*
;
Vitamins*
2.Effectiveness of Thrombectomy in Stroke According to Baseline Prognostic Factors: Inverse Probability of Treatment Weighting Analysis of a Population-Based Registry
Salvatore RUDILOSSO ; José RÍOS ; Alejandro RODRÍGUEZ ; Meritxell GOMIS ; Víctor VERA ; Manuel GÓMEZ-CHOCO ; Arturo RENÚ ; Núria MATOS ; Laura LLULL ; Francisco PURROY ; Sergio AMARO ; Mikel TERCEÑO ; Víctor OBACH ; Joaquim SERENA ; Joan MARTÍ-FÀBREGAS ; Pedro CARDONA ; Carlos MOLINA ; Ana RODRÍGUEZ-CAMPELLO ; David CÁNOVAS ; Jerzy KRUPINSKI ; Xavier USTRELL ; Ferran TORRES ; Luis San ROMÁN ; Mercè SALVAT-PLANA ; Francesc Xavier JIMÉNEZ-FÀBREGA ; Ernest PALOMERAS ; Esther CATENA ; Carla COLOM ; Dolores COCHO ; Juanjo BAIGES ; Josep Maria ARAGONES ; Gloria DIAZ ; Xavier COSTA ; María Cruz ALMENDROS ; Maria RYBYEBA ; Miquel BARCELÓ ; Dolors CARRIÓN ; Matilde Núria LÒPEZ ; Eduard SANJURJO ; Natalia Pérez DE LA OSSA ; Xabier URRA ; Ángel CHAMORRO ;
Journal of Stroke 2021;23(3):401-410
Background:
and Purpose In real-world practice, the benefit of mechanical thrombectomy (MT) is uncertain in stroke patients with very favorable or poor prognostic profiles at baseline. We studied the effectiveness of MT versus medical treatment stratifying by different baseline prognostic factors. Methods Retrospective analysis of 2,588 patients with an ischemic stroke due to large vessel occlusion nested in the population-based registry of stroke code activations in Catalonia from January 2017 to June 2019. The effect of MT on good functional outcome (modified Rankin Score ≤2) and survival at 3 months was studied using inverse probability of treatment weighting (IPTW) analysis in three pre-defined baseline prognostic groups: poor (if pre-stroke disability, age >85 years, National Institutes of Health Stroke Scale [NIHSS] >25, time from onset >6 hours, Alberta Stroke Program Early CT Score <6, proximal vertebrobasilar occlusion, supratherapeutic international normalized ratio >3), good (if NIHSS <6 or distal occlusion, in the absence of poor prognostic factors), or reference (not meeting other groups’ criteria).
Results:
Patients receiving MT (n=1,996, 77%) were younger, had less pre-stroke disability, and received systemic thrombolysis less frequently. These differences were balanced after the IPTW stratified by prognosis. MT was associated with good functional outcome in the reference (odds ratio [OR], 2.9; 95% confidence interval [CI], 2.0 to 4.4), and especially in the poor baseline prognostic stratum (OR, 3.9; 95% CI, 2.6 to 5.9), but not in the good prognostic stratum. MT was associated with survival only in the poor prognostic stratum (OR, 2.6; 95% CI, 2.0 to 3.3).
Conclusions
Despite their worse overall outcomes, the impact of thrombectomy over medical management was more substantial in patients with poorer baseline prognostic factors than patients with good prognostic factors.
3.Effectiveness of Thrombectomy in Stroke According to Baseline Prognostic Factors: Inverse Probability of Treatment Weighting Analysis of a Population-Based Registry
Salvatore RUDILOSSO ; José RÍOS ; Alejandro RODRÍGUEZ ; Meritxell GOMIS ; Víctor VERA ; Manuel GÓMEZ-CHOCO ; Arturo RENÚ ; Núria MATOS ; Laura LLULL ; Francisco PURROY ; Sergio AMARO ; Mikel TERCEÑO ; Víctor OBACH ; Joaquim SERENA ; Joan MARTÍ-FÀBREGAS ; Pedro CARDONA ; Carlos MOLINA ; Ana RODRÍGUEZ-CAMPELLO ; David CÁNOVAS ; Jerzy KRUPINSKI ; Xavier USTRELL ; Ferran TORRES ; Luis San ROMÁN ; Mercè SALVAT-PLANA ; Francesc Xavier JIMÉNEZ-FÀBREGA ; Ernest PALOMERAS ; Esther CATENA ; Carla COLOM ; Dolores COCHO ; Juanjo BAIGES ; Josep Maria ARAGONES ; Gloria DIAZ ; Xavier COSTA ; María Cruz ALMENDROS ; Maria RYBYEBA ; Miquel BARCELÓ ; Dolors CARRIÓN ; Matilde Núria LÒPEZ ; Eduard SANJURJO ; Natalia Pérez DE LA OSSA ; Xabier URRA ; Ángel CHAMORRO ;
Journal of Stroke 2021;23(3):401-410
Background:
and Purpose In real-world practice, the benefit of mechanical thrombectomy (MT) is uncertain in stroke patients with very favorable or poor prognostic profiles at baseline. We studied the effectiveness of MT versus medical treatment stratifying by different baseline prognostic factors. Methods Retrospective analysis of 2,588 patients with an ischemic stroke due to large vessel occlusion nested in the population-based registry of stroke code activations in Catalonia from January 2017 to June 2019. The effect of MT on good functional outcome (modified Rankin Score ≤2) and survival at 3 months was studied using inverse probability of treatment weighting (IPTW) analysis in three pre-defined baseline prognostic groups: poor (if pre-stroke disability, age >85 years, National Institutes of Health Stroke Scale [NIHSS] >25, time from onset >6 hours, Alberta Stroke Program Early CT Score <6, proximal vertebrobasilar occlusion, supratherapeutic international normalized ratio >3), good (if NIHSS <6 or distal occlusion, in the absence of poor prognostic factors), or reference (not meeting other groups’ criteria).
Results:
Patients receiving MT (n=1,996, 77%) were younger, had less pre-stroke disability, and received systemic thrombolysis less frequently. These differences were balanced after the IPTW stratified by prognosis. MT was associated with good functional outcome in the reference (odds ratio [OR], 2.9; 95% confidence interval [CI], 2.0 to 4.4), and especially in the poor baseline prognostic stratum (OR, 3.9; 95% CI, 2.6 to 5.9), but not in the good prognostic stratum. MT was associated with survival only in the poor prognostic stratum (OR, 2.6; 95% CI, 2.0 to 3.3).
Conclusions
Despite their worse overall outcomes, the impact of thrombectomy over medical management was more substantial in patients with poorer baseline prognostic factors than patients with good prognostic factors.
4.Vascular Calcification: Current Genetics Underlying This Complex Phenomenon.
Nonanzit PÉREZ-HERNÁNDEZ ; Gad APTILON-DUQUE ; Ruben BLACHMAN-BRAUN ; Gilberto VARGAS-ALARCÓN ; Adrián Asael RODRÍGUEZ-CORTÉS ; Shely AZRAD-DANIEL ; Rosalinda POSADAS-SÁNCHEZ ; José Manuel RODRÍGUEZ-PÉREZ
Chinese Medical Journal 2017;130(9):1113-1121
OBJECTIVEVascular calcification is the consequence of the complex interaction between genetic, environmental, and vascular factors, which ultimately lead to the deposition of calcium in the tunica intima (atherosclerotic calcification) or tunica media (Mönckenberg's sclerosis). Vascular calcification is also closely related to other pathologies, such as diabetes mellitus, dyslipidemia, and chronic kidney disease. It has been concluded that the degree of vascular calcification may vary from person to person, even if the associated pathologies and environmental factors are the same. Therefore, this suggests an important genetic contribution to the development of vascular calcification. This review aimed to find the most recent evidence about vascular calcification pathophysiology regarding the genetic aspects and molecular pathways.
DATA SOURCESWe conducted an exhaustive search in Scopus, EBSCO, and PubMed with the keywords "genetics and vascular calcification", "molecular pathways, genetic and vascular calcification" and included the main articles from January 1995 up to August 2016. We focused on the most recent evidence about vascular calcification pathophysiology regarding the genetic aspects and molecular pathways.
STUDY SELECTIONThe most valuable published original and review articles related to our objective were selected.
RESULTSVascular calcification is a multifactorial disease; thus, its pathophysiology cannot be explained by a single specific factor, rather than by the result of the association of several genetic variants, molecular pathway interactions, and environmental factors that promote its development.
CONCLUSIONAlthough several molecular aspects of this mechanism have been elucidated, there is still a need for a better understanding of the factors that predispose to this disease.
Diabetes Mellitus ; metabolism ; physiopathology ; Dyslipidemias ; metabolism ; physiopathology ; Humans ; Kidney Failure, Chronic ; metabolism ; physiopathology ; Renal Insufficiency, Chronic ; metabolism ; physiopathology ; Tunica Intima ; metabolism ; physiopathology ; Tunica Media ; metabolism ; physiopathology ; Vascular Calcification ; metabolism ; physiopathology
5.Role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in Peyronie's disease: a new diagnostic approach to predict the stage of the disease?
Esther GARCIA ROJO ; Borja GARCÍA GÓMEZ ; Rocio SANTOS-PÉREZ DE LA BLANCA ; Celeste MANFREDI ; Manuel ALONSO ISA ; José MEDINA POLO ; Alfredo RODRÍGUEZ ANTOLÍN ; Javier ROMERO OTERO
Asian Journal of Andrology 2021;23(3):325-329
Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been associated with multiple entities and several types of cancers. They can be assumed as markers of inflammatory imbalance. The objective of this study is to evaluate the NLR and PLR in Peyronie's disease (PD) and to establish a comparison of its values in the acute and chronic stages. We recruited patients with PD from March 2018 to March 2019. The patients enrolled underwent medical and sexual history as well as a physical examination. The values of blood count of each patient were collected both in the acute and chronic stages. Wilcoxon test was used to compare the acute and chronic stage ratios. Kruskal-Wallis test was carried out to evaluate the impact of treatments on the ratios. To identify cutoff values, we used sensibility and specificity tables and receiver operating characteristic (ROC) curves. A total of 120 patients were enrolled. Their mean age was 55.85 (range: 18-77) years and the mean penile curvature was 48.43° (range: 10°-100°). In the acute stage, the mean NLR was 2.35 and the mean PLR was 111.22. These ratios, in the chronic stage, were 1.57 and 100.00, respectively. Statistically significant differences between acute and stable stages for both indices were found (NLR: P< 0.0001; PLR: P= 0.0202). The optimal cutoff for classification in acute or stable stage was 2 for NLR and 102 for PLR. According to our results, with an ordinary blood count, we could have important indications regarding the disease stage of the patient, and consequently on the most appropriate type of therapy to choose.